CSI Market
Sign In | Register

Ligand Pharmaceuticals Incorporated (LGND) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LGND Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Ligand Pharmaceuticals Incorporated's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1,006.70
Short-term Investments, Total270.74
Cash & Short-term Investments1,276.00
Accounts receivable67.01
Income Taxes Receivable, Current NO2.91
Inventories10.26
Derivative Asset, Current DE18.84
Other Current Assets0.00
Total Current Assets1,457.12
Equipment/Property/Plant Net3.40
Goodwill net101.54
Intangible Assets310.79
Long-term investments114.48
Derivative Asset, Noncurrent DE117.91
Other Assets, Noncurrent261.30
Total Assets2,185.88
Liabilities
Accounts Payable, Current AC9.41
Accrued Liabilities, Current AC31.87
Derivative Liability, Current DE0.82
Other Liabilities, Current1.42
Taxes Payable, Current, Total3.22
Total Current Liabilities46.74
Long-term debt1,126.59
Total Long-term Debt1,126.59
Disposal Group, Including Discontinued Operation, Liabilities LI0.00
Other liabilities, Noncurrent45.03
Current Portion Of Liability For Contingent Value Rights0.28
Liability For Contingent Value Rights3.50
Total Liabilities1,218.36
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock379.77
Retained Earnings / Accumulated Deficit583.25
Accumulated Other Comprehensive Income4.48
Other Equity4.48
Common Stockholder's Equity967.52
Total Stockholder's Equity967.52
Liabilities & Stockholder's Equity2,185.88
4 historic quarters locked

Sign in to unlock the full Ligand Pharmaceuticals Incorporated balance sheet history.

Sign In Create Free Account

About Ligand Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000886163-26-000044

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.